COM:OLEMA
Olema Pharmaceuticals Inc (Olema Oncology)
- Stock
Last Close
12.72
12/11 21:00
Market Cap
649.39M
Beta: -
Volume Today
640.33K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -159.50K - | -159.50K 0% | |||||
average payables | 525.50K - | 827K 57.37% | 371K 55.14% | 198.50K 46.50% | 1.54M 673.80% | ||
average receivables | 159.50K - | 159.50K 0% | |||||
book value per share | -0.45 - | -0.75 68.75% | 48.16 6,508.85% | 7.20 85.05% | 4.94 31.40% | 0.01 99.89% | |
capex per share | -0.01 - | -0.04 399.64% | -0.01 77.22% | ||||
capex to depreciation | -5.09 - | -9.66 89.80% | -1.02 89.48% | ||||
capex to operating cash flow | 0.00 - | 0.03 1,002.25% | 0.00 85.76% | ||||
capex to revenue | |||||||
cash per share | 0.22 - | 0.00 97.84% | 48.22 999,577.22% | 14.19 70.58% | 5.11 63.97% | 0.01 99.89% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.01 - | 0.01 7.03% | 0.01 26.63% | ||||
debt to equity | 0.01 - | 0.01 12.34% | 0.01 26.68% | ||||
dividend yield | |||||||
earnings yield | -0.00 - | -0.01 96.45% | -0.07 979.26% | -0.19 184.17% | -1.05 446.37% | -0.00 99.99% | |
enterprise value | 687.68M - | 690.76M 0.45% | -956.82K 100.14% | 85.99M 9,086.68% | 76.85M 10.62% | 634.75B 825,840.35% | |
enterprise value over ebitda | -332.70 - | -160.38 51.79% | 0.04 100.03% | -1.21 2,813.60% | -0.72 40.61% | -6.05K 841,790.86% | |
ev to operating cash flow | -316.03 - | -224.20 29.06% | 0.05 100.02% | -1.70 3,621.98% | -0.94 44.79% | -7.58K 809,445.25% | |
ev to sales | |||||||
free cash flow per share | -0.15 - | -0.22 41.59% | -2.84 1,198.34% | -1.32 53.39% | -2.06 55.85% | -0.00 99.91% | |
free cash flow yield | -0.00 - | -0.00 41.59% | -0.06 1,223.18% | -0.14 139.40% | -0.84 495.42% | -0.00 99.98% | |
graham net net | -0.45 - | -0.76 66.53% | 47.56 6,391.75% | 13.90 70.78% | 4.66 66.47% | 0.01 99.89% | |
graham number | 1.25 - | 2.28 82.07% | 59.27 2,505.18% | 17.05 71.24% | 16.88 0.95% | 0.02 99.90% | |
income quality | 0.99 - | 0.71 27.93% | 0.90 25.80% | 0.71 20.61% | 0.78 9.84% | 0.87 10.61% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -74.25 - | -32.97 - | 299.69 - | ||||
interest debt per share | 0.00 - | 0.09 - | 0.08 10.52% | 0.06 33.66% | 0.00 99.90% | ||
inventory turnover | |||||||
invested capital | 0.01 - | 0.01 12.34% | 0.01 26.68% | ||||
market cap | 690.83M - | 690.83M 0% | 337.59M 51.13% | 369.95M 9.58% | 97.99M 73.51% | 634.82B 647,745.76% | |
net current asset value | -6.31M - | -10.62M 68.43% | 337.55M 3,277.56% | 275.87M 18.27% | 190.80M 30.84% | 243.46M 27.60% | |
net debt to ebitda | 1.52 - | 0.02 98.96% | 15.77 99,784.00% | 3.99 74.67% | 0.20 95.05% | 0.63 218.87% | |
net income per share | -0.16 - | -0.31 96.45% | -3.24 959.00% | -1.79 44.68% | -2.56 43.01% | -0.00 99.92% | |
operating cash flow per share | -0.15 - | -0.22 41.59% | -2.83 1,194.69% | -1.28 54.67% | -2.05 59.99% | -0.00 99.91% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.67 - | -32.70 4,768.08% | -0.07 99.80% | -0.24 260.63% | -0.48 98.61% | -0.35 26.64% | |
revenue per share | |||||||
roe | 0.35 - | 0.41 16.42% | -0.07 116.52% | -0.25 270.03% | -0.52 108.47% | -0.38 26.69% | |
roic | 0.32 - | 0.41 28.49% | -0.07 116.06% | -0.24 273.70% | -0.52 111.09% | -0.41 21.50% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | -0.45 - | -0.75 68.75% | 48.16 6,508.85% | 7.20 85.05% | 4.94 31.40% | 0.01 99.89% | |
stock based compensation to revenue | |||||||
tangible asset value | -6.28M - | -10.59M 68.75% | 338.14M 3,291.78% | 284.57M 15.84% | 197.55M 30.58% | 253.90M 28.52% | |
tangible book value per share | -0.45 - | -0.75 68.75% | 48.16 6,508.85% | 7.20 85.05% | 4.94 31.40% | 0.01 99.89% | |
working capital | 3.04M - | -1.27M 141.93% | 337.55M 26,574.67% | 278.23M 17.57% | 192.35M 30.87% | 244.89M 27.32% |
All numbers in (except ratios and percentages)